Media Articles Related to Ortho (Ethinyl Estradiol)
Pain management: VQ OrthoCare introduces Avid IF 2 to product lineup
Source: Pain / Anesthetics News From Medical News Today [2015.01.05]
VQ OrthoCare, the leading provider of non-invasive, non-drug medical solutions focused on bone, joint and soft-tissue conditions, has introduced the Avid IF 2TM to its lineup of electrotherapy...
Source: MedicineNet Tilt-table Test Specialty [2014.01.08]
Title: Orthostatic Hypotension
Category: Diseases and Conditions
Created: 6/11/2009 12:00:00 AM
Last Editorial Review: 1/8/2014 12:00:00 AM
Let's Stop Shunning Industry in Academe
Source: MedPage Today Surgery [2015.01.13]
(MedPage Today) -- Company-sponsored demos and seminars enhance orthopedic surgery training.
EOS imaging obtains FDA approval for hipEOS, the first 3D stereoradiographic planning software for hip arthroplasty
Source: Bones / Orthopedics News From Medical News Today [2014.12.22]
EOS imaging, the pioneer in orthopaedic 2D/3D imaging, announced today that the U.S.
Make the Diagnosis: A Man with Wrist Pain for Three Months
Source: MedPage Today Dermatology [2014.12.22]
(MedPage Today) -- Case Study: A thirty-three-year-old man presented to a Tennessee orthopaedic clinic with a three-month history of pain in the left wrist. He reported no recent trauma to the extremity, no respiratory illness preceding the wrist pain, and no fever, chills, or other constitutional symptoms. Physical examination of the left wrist revealed tenderness over the distal part of the radius but no palpable masses or overlying skin changes. The patient had full range of wrist motion and was neurologically intact.
Radiographs of the wrist, shown here, demonstrated a radiolucent lesion in the lateral aspect of the distal radial epiphysis, with sharp borders and mild cortical thinning. Open biopsy revealed a lesion composed of soft, reddish-brown tissue. The intraoperative frozen section revealed multinucleated giant cells with monotonous mononuclear stromal cells. The lesion was removed; the cavity was then treated with a power burr and argon beam coagulator and filled with gentamicin-impregnated polymethylmethacrylate bone cement.
Published Studies Related to Ortho (Ethinyl Estradiol)
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90
mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual
and premenstrual syndrome (PMS)... CONCLUSIONS: These data, although not consistent, indicate that continuous LNG/EE
Bond strength of orthodontic light-cured resin-modified glass ionomer cement. [2011.04]
The purpose of this study was to compare the bond strengths and debonded interfaces achieved with light-cured resin-modified glass ionomer cement (RMGIC) and conventional light-cured composite resin. In addition, the effects of acid etching and water contamination were examined... Enamel surfaces, with or without water contamination and with or without acid etching, had the same or a greater bond strength than Transbond.
In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets. [2010.12]
INTRODUCTION: One common negative side effect of orthodontic treatment with fixed appliances is the development of incipient caries lesions around brackets, particularly in patients with poor oral hygiene. Bio-available minerals from cement containing amorphous calcium phosphate (ACP) might facilitate remineralization and inhibit lesion development. Our objective was to compare the potential of ACP-containing resin cement, fluoride varnish, resin sealer, and MI Paste (GC America, Alsip, Ill) under similar in-vitro conditions to prevent incipient caries lesions next to brackets on teeth... CONCLUSIONS: Both light-cured filled resin (Pro-seal) and fluoride varnish (Vanish) might prevent enamel demineralization next to orthodontic brackets exposed to cariogenic conditions, but the observed positive effects of Aegis-Ortho and MI Paste were not significant. Copyright (c) 2010 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.
Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects. [2010.12]
BACKGROUND: Limited orthodontics are shown to be effective in the correction of infrabony defects. Studies have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze-dried bone allograft (DFDBA) to treat infrabony defects. This study aims to compare the clinical efficacy of limited orthodontics combined with EMD/DFDBA in the treatment of 2- or 3-wall infrabony defects... CONCLUSION: Although both treatment modalities were effective in managing 2- or 3-wall infrabony defects, limited orthodontics provided an additional benefit to EMD/DFDBA in 2-wall defects.
Effects of different topical agents on enamel demineralization around orthodontic brackets: an in vivo and in vitro study. [2010.09]
BACKGROUND: The aim of this study was to evaluate the in vivo and in vitro effects of a casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and fluoride containing topical agents in reducing enamel demineralization around orthodontic brackets, and to compare this with a control group... CONCLUSIONS: In vivo and in vitro evaluations indicated that CPP-ACP and fluoride containing agents successfully inhibited caries around orthodontic brackets.
Clinical Trials Related to Ortho (Ethinyl Estradiol)
A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Subjects [Recruiting]
The purpose of this study is to look at how the body processes oral contraceptive (OC),
using Ortho-Cyclen, as a commonly prescribed combination oral contraceptive in healthy
female subjects, and the effect of dulaglutide on how Ortho-Cyclen is processed by the body.
Information about any side effects that may occur will also be collected.
Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) [Recruiting]
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada) [Recruiting]
The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho
Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50
years of age who request oral contraceptive protection. Subjects on a LNG, NGM, or
norethindrone/norethindrone acetate containing oral contraceptive in a 21-day regimen
suffering from hormone withdrawal-associated symptoms such of pelvic pain or headache or
both, and willing to continue OC use but to switch to SH T00658ID or Ortho Tri-Cyclen Lo.
Discontinuation of Orthokeratology on Eyeball Elongation in Myopic Children [Recruiting]
The primary aim of this study is to compare eyeball elongation in existing ortho-k subjects
who stop the treatment with subjects who continue ortho-k lens wear and control subjects
wearing single-vision glasses.
Drug Interaction - Oral Contraceptive [Completed]
The purpose of this study is to administer a combined oral contraceptive containing ethinyl
estradiol and norgestimate with the HIV treatment of efavirenz to healthy females in order to
assess if the concentrations of the oral contraceptives change. The safety of this treatment
regimen will also be studied.